These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 8052939)

  • 1. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
    Müller G; Kiricuta IC; Stiess J; Bohndorf W
    Strahlenther Onkol; 1994 Jul; 170(7):400-7. PubMed ID: 8052939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumonitis after radiotherapy of bronchial carcinoma: incidence and influencing factors].
    Schraube P; Schell R; Wannenmacher M; Drings P; Flentje M
    Strahlenther Onkol; 1997 Jul; 173(7):369-78. PubMed ID: 9265259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of reduction of radiation dosage on the incidence of radiation-induced pneumonitis, pulmonary fibrosis and pericarditis after mediastinal irradiation in the treatment of lymphogranulomatosis].
    Libera T; Mücke R; Cihal S; Knauerhase H; Ziegler PG; Hamann D; Kundt G; Strietzel M
    Strahlenther Onkol; 1997 Jun; 173(6):330-4. PubMed ID: 9235640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects.
    Dörr W; Bertmann S; Herrmann T
    Strahlenther Onkol; 2005 Sep; 181(9):567-73. PubMed ID: 16170483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation pneumonitis following multi-field radiation therapy.
    Tada T; Minakuchi K; Matsui K; Kawase I; Fukuda H; Nakajima T
    Radiat Med; 2000; 18(1):59-61. PubMed ID: 10852657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
    Oetzel D; Schraube P; Hensley F; Sroka-Pérez G; Menke M; Flentje M
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):455-60. PubMed ID: 7673033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary complications after radiotherapy in lung cancer].
    Li YM; Lue XS
    Rinsho Hoshasen; 1989 Jul; 34(7):827-30. PubMed ID: 2795931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
    Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
    Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury.
    Morgan GW; Breit SN
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):361-9. PubMed ID: 7836090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
    Niibe Y; Hayakawa K; Masuda N; Yoshimura H
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Computed tomographic determination of the target volume and the evaluation of remission after radiation of bronchial carcinoma].
    Feyerabend T; Schmitt R; Richter E; Bohndorf W
    Strahlenther Onkol; 1990 Jun; 166(6):405-10. PubMed ID: 2163548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
    Willner J; Baier K; Caragiani E; Tschammler A; Flentje M
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):382-9. PubMed ID: 11872283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer.
    Graham MV; Purdy JA; Emami B; Matthews JW; Harms WB
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):993-1000. PubMed ID: 7493861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
    Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
    Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung cancer--hopelessness in inoperability? A 10-year follow-up].
    Schwegler N
    Strahlenther Onkol; 1997 Jul; 173(7):352-61. PubMed ID: 9265257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.